Guided Therapeutics Inc (GTHP)
Guided Therapeutics, Inc. is a healthcare company listed on OTC Markets as common stock under the ticker GTHP. The company focuses on medical technology and develops medical devices, including LuViva, a non-invasive cervical cancer detection device. LuViva is designed for point-of-care cervical scanning and uses light-based analysis to help identify cervical cancers and precancerous conditions without pain or invasive procedures. Founded in 1992 and based in Peachtree Corners, Georgia, the company changed its name from SpectRx, Inc. in February 2008.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-GTHP
|
$0.27
|
4.6% Upside
|
Fair
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 14, 2026
|
-6.8x
|
-4.5x
|
34.6x
|
26.548 M
|
29.681 M
|
9.3%
|
41.5%
|
-143.6
|
—
|
34.8%
|
